{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:34:07Z","timestamp":1788849247295,"version":"build-2803163510"},"reference-count":110,"publisher":"Impact Journals, LLC","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,16]]},"DOI":"10.18632\/oncotarget.15411","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"33911-33921","source":"Crossref","is-referenced-by-count":64,"title":["Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges"],"prefix":"10.18632","volume":"8","author":[{"given":"Jin-Fang","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Cong","family":"Lao","sequence":"additional","affiliation":[{"name":"Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Hong","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Yan\u2019An Hospital Affiliated to Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Chemotherapy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"issue":"66","key":"1","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"2016","author":"He","journal-title":"CA Cancer J Clin"},{"issue":"66","key":"2","first-page":"7","article-title":"Cancer statistics, 2016","volume":"2016","author":"Jemal","journal-title":"CA Cancer J Clin"},{"issue":"137","key":"3","first-page":"850","article-title":"A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma","volume":"2009","author":"Schwartz","journal-title":"Gastroenterology"},{"issue":"37","key":"4","first-page":"2435","article-title":"Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma","volume":"2016","author":"Zhong","journal-title":"Tumour Biol"},{"issue":"8","key":"5","doi-asserted-by":"publisher","first-page":"18296","DOI":"10.18632\/oncotarget.15433","article-title":"Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study","volume":"2017","author":"Li","journal-title":"Oncotarget"},{"issue":"21","key":"6","first-page":"3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"2015","author":"Lee","journal-title":"World J Gastroenterol"},{"issue":"29","key":"7","first-page":"62","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"1999","author":"Bruix","journal-title":"Hepatology"},{"issue":"48","key":"8","first-page":"103","article-title":"Hepatocellular carcinoma in Central Europe: prognostic features and survival","volume":"2001","author":"Gangl","journal-title":"Gut"},{"issue":"22","key":"9","first-page":"7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016","volume":"2016","author":"Chok","journal-title":"World J Gastroenterol"},{"issue":"379","key":"10","first-page":"1245","article-title":"Hepatocellular carcinoma","volume":"2012","author":"Bruix","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012(48):599\u2013641.","DOI":"10.1016\/j.ejca.2011.12.021"},{"issue":"53","key":"12","first-page":"1020","article-title":"Management of hepatocellular carcinoma: an update","volume":"2011","author":"Sherman","journal-title":"Hepatology"},{"issue":"4","key":"13","first-page":"439","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"2010","author":"Jia","journal-title":"Hepatol Int"},{"issue":"12","key":"14","first-page":"302","article-title":"Surgical treatment of hepatocellular carcinoma: expert consensus statement","volume":"2010","author":"Nagorney","journal-title":"HPB (Oxford)"},{"issue":"29","key":"15","first-page":"339","article-title":"HCC Expert Panel of Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version","volume":"2011","author":"Makuuchi","journal-title":"Dig Dis"},{"key":"16","article-title":"Intermediate-stage HCC\u2014upfront resection can be feasible","author":"Li","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"32","key":"17","first-page":"348","article-title":"Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions","volume":"2012","author":"Sangro","journal-title":"Semin Liver Dis"},{"key":"18","volume-title":"The General Rules for the Clinical and Pathological Study of Primary Liver Cancer","author":"Liver Cancer Study Group of Japan","year":"1987","edition":"2"},{"key":"19","volume-title":"The general rules for the clinical and pathological study of primary liver cancer","author":"Liver Cancer Study Group of Japan","year":"2003","edition":"2"},{"issue":"44","key":"20","first-page":"219","article-title":"Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus","volume":"2014","author":"Yamamoto","journal-title":"Surg Today"},{"issue":"46","key":"21","first-page":"372","article-title":"Report of the 19th follow-up survey of primary liver cancer in Japan","volume":"2016","author":"Matsuyama","journal-title":"Hepatol Res"},{"issue":"40","key":"22","first-page":"1043","article-title":"Report of the 18th Nationwide Follow-up Survey of Primary Liver Cancer in Japan","volume":"2010","author":"Monden","journal-title":"Hepatol Res"},{"issue":"12","key":"23","first-page":"374","article-title":"Clinicopathological staging of portal vein tumor thrombus in hepatocellular carcinoma and its significance","volume":"2006","author":"Yang","journal-title":"Chin J Hepatobiliary Surg"},{"issue":"54","key":"24","first-page":"499","article-title":"Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein","volume":"2007","author":"Yuxiang","journal-title":"Hepatogastroenterology"},{"issue":"18","key":"25","first-page":"74","article-title":"A new classification for hepatocellular carcinoma with portal vein tumor thrombus","volume":"2011","author":"Cheng","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"13","key":"26","first-page":"86","article-title":"Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus: a novel classification","volume":"2015","author":"Wen","journal-title":"World J Surg Oncol"},{"issue":"6","key":"27","first-page":"66","article-title":"The surgical management of primary carcinoma of the liver","volume":"1982","author":"Ong","journal-title":"World J Surg"},{"issue":"74","key":"28","first-page":"839","article-title":"Role of surgery in the treatment of primary carcinoma of the liver: a 31-year experience","volume":"1987","author":"Chen","journal-title":"Br J Surg"},{"issue":"108","key":"29","first-page":"821","article-title":"Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi","volume":"1990","author":"Shimahara","journal-title":"Surgery"},{"issue":"16","key":"30","first-page":"1172","article-title":"Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein","volume":"1992","author":"Washida","journal-title":"World J Surg"},{"issue":"95","key":"31","first-page":"3115","article-title":"Hepatic resection for hepatocellular carcinoma involving a single large tumor, multiple tumors or macrovascular invasion","volume":"2015","author":"Zhong","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"152","key":"32","first-page":"809","article-title":"Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?","volume":"2012","author":"Lee","journal-title":"Surgery"},{"issue":"175","key":"33","first-page":"243","article-title":"Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2012","author":"Cheng","journal-title":"J Surg Res"},{"issue":"38","key":"34","first-page":"490","article-title":"Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis","volume":"2014","author":"Lo","journal-title":"World J Surg"},{"issue":"32","key":"35","first-page":"413","article-title":"Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein","volume":"2015","author":"Uemoto","journal-title":"Dig Surg"},{"issue":"65","key":"36","first-page":"938","article-title":"Liver Cancer Study Group of Japan. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","volume":"2016","author":"Kokudo","journal-title":"J Hepatol"},{"issue":"22","key":"37","first-page":"160","article-title":"Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2016","author":"Kweon","journal-title":"Clin Mol Hepatol"},{"issue":"18","key":"38","first-page":"549","article-title":"Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy","volume":"2016","author":"Meng","journal-title":"HPB (Oxford)"},{"issue":"21","key":"39","first-page":"1825","article-title":"Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis","volume":"2014","author":"Huo","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"40","first-page":"247","article-title":"Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection","volume":"2012","author":"Maehara","journal-title":"HPB (Oxford)"},{"issue":"118","key":"41","first-page":"4725","article-title":"Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"2012","author":"Lau","journal-title":"Cancer"},{"issue":"20","key":"42","first-page":"3754","article-title":"Resection of hepatocellular carcinoma with macroscopic vascular invasion","volume":"2013","author":"Schwartz","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"43","first-page":"2073","article-title":"Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"2010","author":"Cheng","journal-title":"Ann Surg Oncol"},{"issue":"37","key":"44","first-page":"1362","article-title":"Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study","volume":"2013","author":"Wu","journal-title":"World J Surg"},{"issue":"62","key":"45","first-page":"703","article-title":"Curative Analysis of Several Therapeutic Methods for Primary Hepatocellular Carcinoma with Portal Vein Tumor Thrombus","volume":"2015","author":"Fu","journal-title":"Hepatogastroenterology"},{"issue":"257","key":"46","first-page":"929","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group","volume":"2013","author":"Makuuchi","journal-title":"Ann Surg"},{"issue":"18","key":"47","first-page":"287","article-title":"The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"2016","author":"Cheng","journal-title":"HPB (Oxford)"},{"issue":"91","key":"48","first-page":"2841","article-title":"[Combined three-dimensional conformal radiotherapy plus transcatheter arterial chemoembolization and surgical intervention for portal vein tumor thrombus in patients with hepatocellular carcinoma]","volume":"2011","author":"Chu","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"10","key":"49","first-page":"2787","article-title":"A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection","volume":"2015","author":"Guo","journal-title":"Oncol Lett"},{"issue":"21","key":"50","first-page":"246","article-title":"Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2015","author":"Fujiwara","journal-title":"World J Gastroenterol"},{"issue":"20","key":"51","first-page":"17141","article-title":"Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus","volume":"2014","author":"Li","journal-title":"World J Gastroenterol"},{"issue":"44","key":"52","first-page":"761","article-title":"Recurrence and survivals following hepatic resection for hepatocellular carcinoma with major portal\/hepatic vein tumor thrombus","volume":"2014","author":"Zeng","journal-title":"Hepatol Res"},{"issue":"7","key":"53","doi-asserted-by":"publisher","first-page":"38845","DOI":"10.18632\/oncotarget.8642","article-title":"Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis","volume":"2016","author":"Guo","journal-title":"Oncotarget"},{"issue":"95","key":"54","first-page":"e3959","article-title":"Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus","volume":"2016","author":"Du","journal-title":"Medicine (Baltimore)"},{"issue":"260","key":"55","first-page":"329","article-title":"Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma","volume":"2014","author":"Li","journal-title":"Ann Surg"},{"issue":"21","key":"56","first-page":"131","article-title":"Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis","volume":"2015","author":"Qu","journal-title":"Pathol Oncol Res"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001922","article-title":"We\u2019re Still in an Update Process of the BCLC System","author":"Yang","year":"2016","journal-title":"Ann Surg"},{"issue":"65","key":"58","first-page":"1057","article-title":"Should hepatic resection be recommended to patients with hepatocellular carcinoma and portal vein invasion?","volume":"2016","author":"Li","journal-title":"J Hepatol"},{"issue":"94","key":"59","first-page":"e396","article-title":"Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion","volume":"2015","author":"Li","journal-title":"Medicine (Baltimore)"},{"issue":"64","key":"60","first-page":"520","article-title":"Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension","volume":"2015","author":"Li","journal-title":"Gut"},{"issue":"6","key":"61","first-page":"125","article-title":"Controversies and evidence of hepatic resection for hepatocellular carcinoma","volume":"2016","author":"Yang","journal-title":"BBA Clin"},{"issue":"79","key":"62","first-page":"2087","article-title":"The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study","volume":"1997","author":"Kim","journal-title":"Cancer"},{"issue":"29","key":"63","first-page":"430","article-title":"Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival","volume":"2014","author":"Arun","journal-title":"Oman Med J"},{"issue":"25","key":"64","first-page":"32","article-title":"Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors","volume":"2014","author":"Kuo","journal-title":"J Vasc Interv Radiol"},{"key":"65","article-title":"Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus","author":"Chung","year":"2016","journal-title":"Eur Radiol"},{"issue":"27","key":"66","first-page":"526","article-title":"Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization","volume":"2017","author":"Schlachter","journal-title":"Eur Radiol"},{"issue":"72","key":"67","first-page":"463","article-title":"A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2013","author":"Arai","journal-title":"Cancer Chemother Pharmacol"},{"issue":"26","key":"68","first-page":"320","article-title":"Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis","volume":"2015","author":"Chung","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000367737","article-title":"Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment","volume":"2015","author":"Lin","journal-title":"Liver Cancer"},{"issue":"29","key":"70","first-page":"2992","article-title":"Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification","volume":"2012","author":"Zhao","journal-title":"Med Oncol"},{"issue":"19","key":"71","first-page":"4679","article-title":"Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2013","author":"Yoon","journal-title":"World J Gastroenterol"},{"issue":"11","key":"72","first-page":"e6","article-title":"Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study","volume":"2015","author":"Xie","journal-title":"Asia Pac J Clin Oncol"},{"issue":"34","key":"73","first-page":"4231","article-title":"Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma","volume":"2014","author":"Yokosuka","journal-title":"Anticancer Res"},{"issue":"140","key":"74","first-page":"211","article-title":"Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial","volume":"2014","author":"Liu","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"75","first-page":"60","article-title":"Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis","volume":"2013","author":"Ren","journal-title":"BMC Gastroenterol"},{"issue":"33","key":"76","first-page":"S124","article-title":"The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma","volume":"1994","author":"Chang","journal-title":"Cancer Chemother Pharmacol"},{"issue":"34","key":"77","first-page":"168","article-title":"The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy","volume":"2016","author":"Kim","journal-title":"Radiat Oncol J"},{"issue":"42","key":"78","first-page":"721","article-title":"Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis","volume":"2012","author":"Kim","journal-title":"Jpn J Clin Oncol"},{"issue":"190","key":"79","first-page":"806","article-title":"Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2014","author":"Kim","journal-title":"Strahlenther Onkol"},{"issue":"7","key":"80","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.18632\/oncotarget.6118","article-title":"Tolerability and efficacy of gamma knife radiosurgery on hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2016","author":"Zhou","journal-title":"Oncotarget"},{"issue":"57","key":"81","first-page":"512","article-title":"Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis\/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy","volume":"2016","author":"Sasaki","journal-title":"J Radiat Res"},{"issue":"8","key":"82","first-page":"e63864","article-title":"Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombosis","volume":"2013","author":"Liu","journal-title":"PLoS One"},{"issue":"56","key":"83","first-page":"325","article-title":"The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"2015","author":"Perng","journal-title":"J Radiat Res"},{"issue":"37","key":"84","first-page":"90","article-title":"Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area","volume":"2017","author":"Yoon","journal-title":"Liver Int"},{"issue":"24","key":"85","first-page":"270","article-title":"Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis","volume":"2015","author":"Martin","journal-title":"Surg Oncol"},{"issue":"27","key":"86","first-page":"812","article-title":"Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres","volume":"2016","author":"Kim","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"87","first-page":"e0154986","article-title":"Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis","volume":"2016","author":"Kim","journal-title":"PLoS One"},{"issue":"36","key":"88","first-page":"1206","article-title":"A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib","volume":"2016","author":"Sangro","journal-title":"Liver Int"},{"issue":"56","key":"89","first-page":"339","article-title":"Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis","volume":"2015","author":"Boucher","journal-title":"J Nucl Med"},{"issue":"121","key":"90","first-page":"2164","article-title":"Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis","volume":"2015","author":"Kim","journal-title":"Cancer"},{"issue":"22","key":"91","first-page":"353","article-title":"A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2016","author":"Qin","journal-title":"Saudi J Gastroenterol"},{"issue":"36","key":"92","first-page":"1715","article-title":"Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?","volume":"2016","author":"Tong","journal-title":"Liver Int"},{"issue":"359","key":"93","first-page":"378","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"2008","author":"Schwartz","journal-title":"N Engl J Med"},{"issue":"10","key":"94","first-page":"25","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"2009","author":"Liang","journal-title":"Lancet Oncol"},{"issue":"7","key":"95","first-page":"696","article-title":"Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis","volume":"2013","author":"Kim","journal-title":"Gut Liver"},{"issue":"36","key":"96","first-page":"6179","article-title":"Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial","volume":"2016","author":"Giorgio","journal-title":"Anticancer Res"},{"issue":"14","key":"97","first-page":"84","article-title":"Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis","volume":"2014","author":"Koizumi","journal-title":"BMC Gastroenterol"},{"issue":"50","key":"98","first-page":"445","article-title":"A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2015","author":"Yang","journal-title":"J Gastroenterol"},{"issue":"20","key":"99","first-page":"1417","article-title":"Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis","volume":"2015","author":"Li","journal-title":"Oncologist"},{"issue":"36","key":"100","first-page":"8271","article-title":"The STORM trial and beyond: narrowing the horizon of adjuvant sorafenib for postoperative hepatocellular carcinoma","volume":"2015","author":"Zhong","journal-title":"Tumour Biol"},{"issue":"8","key":"101","first-page":"957","article-title":"Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial","volume":"2016","author":"Li","journal-title":"World J Hepatol"},{"issue":"3","key":"102","first-page":"182","article-title":"Risk Factors for the Development of Hepatocellular Carcinoma in Thailand","volume":"2015","author":"Phornphutkul","journal-title":"J Clin Transl Hepatol"},{"issue":"35","key":"103","first-page":"9459","article-title":"Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review","volume":"2014","author":"Li","journal-title":"Tumour Biol"},{"issue":"49","key":"104","first-page":"649","article-title":"Postoperative therapy options for hepatocellular carcinoma","volume":"2014","author":"Li","journal-title":"Scand J Gastroenterol"},{"issue":"198","key":"105","first-page":"313","article-title":"Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus","volume":"2009","author":"Zhou","journal-title":"Am J Surg"},{"issue":"2","key":"106","first-page":"43","article-title":"Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"2014","author":"Qi","journal-title":"Mol Clin Oncol"},{"issue":"10","key":"107","first-page":"175","article-title":"Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study","volume":"2016","author":"Lu","journal-title":"Hepatol Int"},{"issue":"35","key":"108","first-page":"2269","article-title":"Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus","volume":"2015","author":"Higai","journal-title":"Anticancer Res"},{"issue":"95","key":"109","first-page":"e3015","article-title":"Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis","volume":"2016","author":"Cheng","journal-title":"Medicine (Baltimore)"},{"issue":"45","key":"110","first-page":"510","article-title":"Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C","volume":"2013","author":"Lu","journal-title":"Dig Liver Dis"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:52:38Z","timestamp":1589136758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":110,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5,16]]}},"alternative-id":["15411","28430610"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15411","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}